| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.18 | 0.002 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.44 | 0.002 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.17 | 0.003 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.004 |